Aurobindo Pharma commissions four plants in Andhra Pradesh including Pen-G facility

The Rs 2,400 crore Pen-G plant is expected to start trial production in April and commercial production in a couple of months and the ramping up of the production will happen during the second quarter of the current fiscal, a senior official of the city-based drug maker had earlier said.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/RTFyfl9
via IFTTT

Read More

It makes sense to make in India and service other markets from here: Elie Chaillot, president & CEO, GE HealthCare

GE HealthCare, a leading medtech company globally, aims to increase manufacturing of its products in India as part of its supply chain diversification strategy. Elie Chaillot, President & CEO of GE HealthCare International, highlights the growth potential in India's healthcare market and emphasizes the country's qualified human resources and competitiveness in 'Make in India'.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/FEHfZuV
via IFTTT

Read More

Can I lower my protein more?

Im 297 lbs, trying to lose weight, and I weight lift and cardio 5 times a week.

My daily protein intake is 220 gram, but I feel like its alot as im trying to force myself to eat protein shakes and foods, and it takes alot from my calories.

Is it possible to go lower than that, while still building and maintaining muscle growth?

My goal is to have low body fat percentage and muscle when I lose weight to look good

from Bodybuilding.com Forums - Nutrition https://ift.tt/noIaBLM

Read More

India's retail chemists ask BJP to include the banning of e-pharmacies in its manifesto

AIOCD said that the online medicine business poses a serious threat to public health, serving as a gateway for counterfeit medications in the country. "We've provided a detailed memorandum outlining these concerns. Allowing it to continue could lead to the monopolisation by big corporations and chains. In the interest of public health and to protect the younger generation from drug abuse, the Government of India should ban E-Pharmacies nationwide," the letter said.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Hkus6ye
via IFTTT

Read More

Wockhardt raises Rs 480 crore to pare debt, fund drug trial

Wockhardt plans to clear debt, fund antibiotic trials with QIP funds. Khorakiwala expects revenue growth, EBITDA rise, and completion of global antibiotic trial for innovations like WCK5222 and WCK4873.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Ti4XZfI
via IFTTT

Read More

Aurobindo Pharma arm extends negotiations deadline with MSD for contract manufacturing operations

Aurobindo Pharma extends deadline for CuraTeQ Biologics and Merck Sharp & Dohme Singapore negotiations on contract manufacturing operations at TheraNym Biologics Pvt Ltd for US biopharmaceutical company till May 2024.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/ROH2bJE
via IFTTT

Read More

Gtffffff

gggggg

from Bodybuilding.com Forums - Nutrition https://ift.tt/PU9RFyS

Read More